Opioids, cancer and mortality with Aleksi Hamina
In this episode Ben Scher talks to Dr Aleksi Hamina from the Norwegian centre for addiction research at the University of Oslo and the Niuvanniemi Hospital in Finland. They discuss a recent paper co-a...
18 Juli 202413min
Cannabis potency and psychotic experiences with Lindsey Hines
In this episode, Dr Rob Calder talks to Dr Lindsey Hines about her study using longitudinal data to examine links between cannabis use, cannabis potency and psychotic experiences. Dr Hines talks about...
6 Juni 202425min
Cannabis use in the US with Jonathan Caulkins
In this episode Dr Elle Wadsworth talks to Professor Jonathan Caulkins about self-reported cannabis use in the US between 1979 and 2022 and how those trends compare with alcohol use over the same peri...
22 Maj 202422min
Integrated care vans with Kathleen Page
In this episode, Ben Scher talks to Dr Kathleen Page about her evaluation of an integrated care van that ran in Baltimore offering healthcare interventions and buprenorphine prescribing. Dr Page discu...
9 Maj 202426min
Smoking and abdominal obesity with Germán Carrasquilla
In this episode Rob Calder talks to Dr Germán Carrasquilla about his study assessing whether smoking cased increases in abdominal obesity or belly fat. They discuss the implications of this kind of fa...
2 Maj 202417min
Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith
In this episode Ben Scher talks to Dr Adam Bakker, Professor Michael Liebrenz and Dr Alexander Smith about their commentary in response to a previous paper by Domzaridou and colleages (2023). They dis...
25 Apr 202423min
Contingency management with Gabriela Khazanov, James, McKay and Richard Rawson
In this episode, Ben Scher talks to Dr Gabriela Khazanov, Professor James McKay and Professor Richard Rawson. They discuss what contingency management is and how effective it can be in treatment setti...
17 Apr 202427min
Xylazine, heroin and drug markets with Caroline Copeland
In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first entere...
9 Apr 202420min
